Advertisement
trendingNowenglish2521699https://zeenews.india.com/health/gambia-cough-syrup-deaths-jaishankar-speaks-to-gambian-counterpart-on-kids-death-assures-serious-investigation-2521699

Gambia cough syrup deaths: Jaishankar speaks to Gambian counterpart on kids' death, assures serious investigation

The Centre has formed a four-member panel to examine the detailed report shared by the World Health Organisation on 66 children's deaths in The Gambia reportedly after using Indian-made medicines.

  • External Affairs Minister Dr S. Jaishankar expressed his deepest condolences to his Gambian counterpart
  • The committee will examine and analyse adverse event reports, causal relationships and all related details shared by WHO
  • It will suitably advise and recommend to the DCGI about the further course of action

Trending Photos

Gambia cough syrup deaths: Jaishankar speaks to Gambian counterpart on kids' death, assures serious investigation Pic: Pixabay

New Delhi: External Affairs Minister Dr S. Jaishankar on Thursday spoke to his Gambian counterpart Dr Mamadou Tangara and conveyed condolences on the deaths of young children allegedly linked to the contaminated cough syrups produced in India. He assured Tangara that serious investigation is being undertaken by appropriate authorities in India to ascertain the facts over World Health Organisation alerts of India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 children`s death".

"In a telecon with Gambian FM Dr Mamadou Tangara, conveyed our deepest condolences on the deaths of young children recently. Underlined that matter is being seriously investigated by appropriate authorities. We agreed to remain in touch," the Minister said in a tweet.



The World Health Organisation had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".

Meanwhile, the centre has formed a four-member panel to analyse and examine the detailed report shared by the World Health Organisation on the issue. The committee will examine and analyse adverse event reports, causal relationships and all related details shared by WHO, and will suitably advise and recommend to the DCGI about the further course of action. The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines.

 

(Disclaimer: This article has been published from a syndicated feed.)

Stay informed on all the latest news, real-time breaking news updates, and follow all the important headlines in india news and world News on Zee News.

NEWS ON ONE CLICK